Effects of the uricogenic agent, 2-ethylamino-1,3,4-thiadiazole in hypoxanthine-guanine phosphoribosyl transferase deficiency.
D000293:Adolescent; D001264:Athetosis; D001393:Azoles / Q000494:pharmacology* / Q000633:toxicity; D002247:Carbon Isotopes; D002547:Cerebral Palsy; D002648:Child; D002819:Chorea; D002986:Clinical Trials as Topic; D005246:Feedback; D005964:Glucosyltransferases; D005998:Glycine / Q000378:metabolism; D006150:Guanine Nucleotides / Q000378:metabolism; D006801:Humans; D007042:Hypoxanthines / Q000378:metabolism; D008607:Intellectual Disability; D008297:Male; D011686:Purine-Pyrimidine Metabolism, Inborn Errors; D012652:Self Mutilation; D013268:Stimulation, Chemical; D014527:Uric Acid / Q000097:blood / Q000652:urine
D001393:Azoles; D002247:Carbon Isotopes; D006150:Guanine Nucleotides; D007042:Hypoxanthines; D014527:Uric Acid; D005964:Glucosyltransferases; D005998:Glycine